Proteostasis Therapeutics, Inc. - Cambridge, MA since Feb 2013
Director, Bioinformatics and Pharmacology
Proteostasis Therapeutics, Inc. - Cambridge, MA since Aug 2009
Senior Scientist II
Dicerna Pharmaceuticals, Inc. Jul 2008 - Aug 2009
Senior Scientist
Elixir Pharmaceuticals, Inc. Feb 2005 - Jul 2008
Senior Scientist
University of Michigan Medical School Sep 1998 - Jan 2005
Postdoctoral Fellow
Education:
Dartmouth Medical School Aug 1993 - Aug 1998
University of New Hampshire 1988 - 1993
Skills:
Drug Discovery In Vivo Bioinformatics Proteomics Biotechnology High Throughput Screening Protein Expression Computational Biology Pharmacology Pharmacokinetics Clinical Development Biochemistry Pharmaceutical Industry Adme Drug Development Bayesian Methods Bayesian Inference Bayesian Statistics Bayesian Networks Molecular Biology Statistics Cro Management R Taxonomy Monte Carlo Simulation Cross Functional Team Leadership Matlab Microarray Analysis Pharmacodynamics Machine Learning Data Analysis Data Mining Experimental Design
Interests:
Children Environment Education Poverty Alleviation Science and Technology Human Rights Health
Ormond MacDougald - Ypsilanti MI, US Kenneth Longo - Ann Arbor MI, US Sarah Ross - Cambridge MA, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A01K067/027
US Classification:
800/014000, 800/018000
Abstract:
The present invention relates to transgenic animal models for altered Wnt expression. The present invention also provides methods for generating animal models and screening methods for identifying biologically active compounds.
Christina Bennett - Ann Arbor MI, US Kurt Hankenson - Ann Arbor MI, US Stephen Harrison - Albany CA, US Kenneth Longo - Ann Arbor MI, US Ormond MacDougald - Ypsilanti MI, US Allan Wagman - Belmont CA, US
International Classification:
A61K031/513 A61K031/506
US Classification:
514269000, 514275000
Abstract:
This invention relates to methods of treating or preventing bone loss by administering to a human or animal subject pyrimidine and pyridine derivatives that inhibit the activity of glycogen synthase kinase 3 (GSK3), to pharmaceutical compositions containing the compounds, and to the use of the compounds and compositions alone or in combination with other pharmaceutically active agents.
Christina N. Bennett - Ann Arbor MI, US Kurt D. Hankenson - Ann Arbor MI, US Stephen D. Harrison - Albany CA, US Kenneth A. Longo - Ann Arbor MI, US Ormond A. MacDougald - Ypsilanti MI, US Allan S. Wagman - Belmont CA, US
This invention relates to methods of treating or preventing bone loss by administering to a human or animal subject pyrimidine and pyridine derivatives that inhibit the activity of glycogen synthase kinase 3 (GSK3), to pharmaceutical compositions containing the compounds, and to the use of the compounds and compositions alone or in combination with other pharmaceutically active agents.
Kenneth Longo 1988 graduate of Pinkerton Academy in Derry, NH is on Classmates.com. See pictures, plan your class reunion and get caught up with Kenneth and other high school alumni
Kenneth Longo 1974 graduate of Sewanhaka High School in Floral park, NY is on Classmates.com. See pictures, plan your class reunion and get caught up with Kenneth and other high ...